Vitrolife AB
(OTC: VTRLY)
|
4:47 PM UTC, 06/28/24 | |||
---|---|---|---|---|
Last: $16.25 | Change: +2.95 | %Change: +22.18% | Volume: 1,158 |
Open: | $ 16.25 | Volume: | 1,158 | |
---|---|---|---|---|
High: | $ 16.25 | Yield(%) | 0.29 | |
Low: | $ 16.25 | P/E Ratio (ttm): | n/a | |
Dividend ($): | 0.05 | Market Cap ($): | 2.20B | |
EPS ($) | -2.65 | Shares Out: | 135.39M |
% Price Change (last 4 weeks): | 22.18 |
---|---|
% Price Change (last 13 weeks): | 22.18 |
% Price Change (last 26 weeks): | 22.18 |
% Price Change (last 52 weeks): | -16.02 |
% Price Change (year to date): | 22.18 |
Return on Equity (%): | -25.29 |
---|---|
Return on Assets (%): | -20.12 |
Return on Invested Capital (%): | 3.89 |
Gross Profit Margin (%): | 49.49 |
---|---|
Net Profit Margin (%): | -109.65 |
Operating Profit Margin (%): | 20.87 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $21.49 |
52-wk low: | $11.45 |
Bid: | $n/a |
Ask: | $n/a |
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. Its products and services include oocyte retrieval needles, sperm processing, IVF media and oil, micromanipulation pipettes, labware, benchtop incubators, time-lapse systems, preimplantation genetic testing, cryopreservation, laser and imaging systems, and lab quality control systems. The firm operates through the following geographical segments: Europe, Middle East, and Africa (EMEA); North and South America; Japan and Pacific; and Asia. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
|
Vitrolife AB
Gustaf Werners Gata 2 Gothenburg VG 421 32 Phone: 46.31.721.80.00 Fax: 46.31.721.80.99 http://www.vitrolife.com |
Earnings (1year) ($): | -2.65 |
---|---|
Annual Dividend ($): | 0.05 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 9.32 |
Cash Flow ($): | -2.38 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 5.44 |
Price/Book (x): | 1.43 |
Price/Cash Flow (x): | 25.25 |
Quick Ratio (x): | 2.69 |
---|---|
Current Ratio (x): | 3.44 |
LT Debt/Equity (x): | 15.26 |
Total Debt/Equity (x): | 16.42 |